| Financial Year |
March 31 2023 |
| Monetary Funds |
469,288,173.65 |
| Held-for-trading Financial Assets |
334,281,279.45 |
| Notes Receivable |
-- |
| Accounts Receivable |
183,984,807.15 |
| Advances to Suppliers |
18,443,855.76 |
| Other Receivables |
3,218,019.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
167,840,778.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,677,662.68 |
| Total Current Assets |
1,197,496,176.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,468,582.35 |
| Investment Properties |
-- |
| Fixed Assetes |
589,184,326.94 |
| Under-construction Projects |
30,508,124.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,284,518.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,212,073.45 |
| Deferred Income Tax Assets |
10,203,182.18 |
| Other Non-Current Assets |
15,203,813.66 |
| Sub-Total of Non-Current Assets |
790,409,032.93 |
| Total Assets |
1,987,905,209.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
128,353,836.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,674,353.21 |
| Taxes Payable |
14,343,891.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,320,864.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,164,866.31 |
| Other Current Liabilities |
29,496.59 |
| Sub-Total of Current Liabilities |
162,093,118.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,010,719.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,129,373.02 |
| Total Liabilities |
180,222,491.50 |
| Paid-In Capital(Or Share Stock) |
132,067,006.00 |
| Capital Surplus |
1,181,489,615.31 |
| Surplus Reserve |
57,534,035.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
436,592,061.38 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,807,682,718.10 |
| Owner's Equity（Stockholder's Equity） |
1,807,682,718.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,987,905,209.60 |
